Table 1.
Adverse Reactions (≥4% Incidence) Reported in the CONFIRM Trial. 1
Adverse reaction | Terlipressin (n = 200) (%) | Placebo (n = 99) (%) |
---|---|---|
Abdominal pain | 19.5 | 6.1 |
Nausea | 16 | 10.1 |
Respiratory failure | 15.5 | 7.1 |
Diarrhea | 13 | 7.1 |
Dyspnea | 12.5 | 5.1 |
Fluid overload | 8.5 | 3 |
Pleural effusion | 5.5 | 0 |
Sepsis | 5.5 | 1 |
Bradycardia | 5 | 0 |
Ischemia-related events | 4.5 | 0 |